(NASDAQ: ATRA) Atara Biotherapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 9.81%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.78%.
Atara Biotherapeutics's earnings in 2025 is -$15,641,000.On average, 1 Wall Street analyst forecast ATRA's earnings for 2025 to be -$20,864,869, with the lowest ATRA earnings forecast at -$20,864,869, and the highest ATRA earnings forecast at -$20,864,869.
In 2026, ATRA is forecast to generate -$2,086,487 in earnings, with the lowest earnings forecast at -$2,086,487 and the highest earnings forecast at -$2,086,487.